Tapewire

Nasdaq · USD

IVF

INVO Fertility, Inc.

Export transactions ↓
Tapewire entity
8473
SEC CIK
0001417926
Parsed reports
136

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 25, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.05 $1,000.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 13

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,272,933

Read SEC document
January 24, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.05 $900.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 12

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,292,933

Read SEC document
January 20, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 40,000 $0.03 $1,000.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 11

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,312,933

Read SEC document
January 20, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.03 $780.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 10

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,352,933

Read SEC document
January 20, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.03 $540.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 9

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,382,933

Read SEC document
January 20, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.03 $560.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 8

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,402,933

Read SEC document
January 20, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.03 $600.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 7

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,422,933

Read SEC document
January 20, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.03 $640.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 6

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,442,933

Read SEC document
January 17, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 40,000 $0.01 $520.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 5

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,462,933

Read SEC document
January 17, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.02 $450.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 4

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,502,933

Read SEC document
January 11, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.01 $420.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 3

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,532,933

Read SEC document
January 10, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 32,500 $0.01 $422.50
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 2

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,562,933

Read SEC document
January 06, 2012 Filed Jul 27, 2017 11:22 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 24,250 $0.01 $291.00
Disclosure

SEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 1

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,595,433

Read SEC document
December 30, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 60,000 $0.01 $600.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 10

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,619,683

Read SEC document
December 29, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.01 $300.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 9

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,679,683

Read SEC document
December 28, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 42,500 $0.01 $425.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 8

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,709,683

Read SEC document
December 21, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 50,000 $0.01 $500.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 7

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,752,183

Read SEC document
December 16, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 45,000 $0.01 $450.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 6

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,802,183

Read SEC document
December 14, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 50,000 $0.01 $500.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 5

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,847,183

Read SEC document
November 14, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 75,000 $0.01 $750.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 4

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,897,183

Read SEC document
November 11, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 5,000 $0.01 $55.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 3

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,972,183

Read SEC document
November 10, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 13,000 $0.01 $143.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 2

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,977,183

Read SEC document
November 09, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.01 $300.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 30

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,010,183

Read SEC document
November 09, 2011 Filed Jul 27, 2017 10:57 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.02 $340.00
Disclosure

SEC source: 0001511164-17-000428 · primary_doc.xml · nonDerivative · entry 1

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,990,183

Read SEC document
November 08, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 150 $0.01 $1.50
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 29

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,040,183

Read SEC document
November 03, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 40,000 $0.01 $440.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 28

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,040,333

Read SEC document
October 20, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 27,700 $0.02 $554.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 27

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,080,333

Read SEC document
October 19, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 40,000 $0.02 $720.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 26

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,108,033

Read SEC document
October 18, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.02 $510.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 25

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,148,033

Read SEC document
October 14, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 10,000 $0.02 $180.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 24

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,178,033

Read SEC document
October 14, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 10,000 $0.02 $160.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 23

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,188,033

Read SEC document
October 14, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 20,000 $0.02 $300.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 22

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,198,033

Read SEC document
September 26, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.02 $600.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 21

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,218,033

Read SEC document
September 26, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 30,000 $0.03 $960.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 20

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,248,033

Read SEC document
September 23, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 8,000 $0.02 $160.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 19

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,278,033

Read SEC document
September 22, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Restricted) 10,000 $0.02 $220.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 18

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,286,033

Read SEC document
September 21, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading + restricted) 20,000 $0.02 $480.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 17

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,296,033

Read SEC document
September 20, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 2,000 $0.03 $50.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 16

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,316,033

Read SEC document
September 16, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 10,000 $0.03 $280.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 15

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,318,033

Read SEC document
September 15, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 500 $0.03 $16.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 14

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,328,033

Read SEC document
September 13, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 4,000 $0.03 $128.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 13

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,328,533

Read SEC document
September 12, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 1,541 $0.04 $58.56
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 12

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,332,533

Read SEC document
September 06, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 30,000 $0.04 $1,110.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 11

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,334,074

Read SEC document
August 25, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 10,000 $0.03 $300.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 10

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,364,074

Read SEC document
August 24, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 6,718 $0.03 $201.54
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 9

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,374,074

Read SEC document
August 11, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 19,500 $0.02 $409.50
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 8

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,380,792

Read SEC document
August 03, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 30,000 $0.03 $900.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 7

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,400,292

Read SEC document
July 25, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 32,000 $0.04 $1,120.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 6

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,430,292

Read SEC document
July 18, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 20,000 $0.04 $700.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 5

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,462,292

Read SEC document
July 15, 2011 Filed Jul 27, 2017 10:48 UTC
Ranoux ClaudeDirector · President · 10% owner
Disposition to issuerINVO Bioscience Common Stock (Free trading) 20,000 $0.04 $700.00
Disclosure

SEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 4

Ranoux Claude · CIK 0001479791 · Director · President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,482,292

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.